Alessandro Rambaldi to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Alessandro Rambaldi has written about Drug Resistance, Neoplasm.
Connection Strength
0.545
-
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia. Handb Exp Pharmacol. 2018; 249:231-250.
Score: 0.533
-
Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3. Blood. 2003 Jun 01; 101(11):4589-97.
Score: 0.012